Chemomab Therapeutics Ltd.
Overview
Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company focused on developing innovative therapeutics for the treatment of fibrotic and inflammatory diseases. The company is committed to advancing its pipeline of monoclonal antibody-based treatments to address unmet medical needs in these therapeutic areas.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Chemomab Therapeutics Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Chemomab Therapeutics Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.